Pharmaceutical Technology

MARCH 27, 2023

Regenerative medicines in early-stage development (preclinical, discovery, or investigational new drug [IND]/ clinical trial application [CTA] filed status) have seen a change in drug targets compared to therapies in late-stage development (Phase II to pre-registration stage).

Medicine 246

Medicine Gene Therapy Gene Dermatology 246

Pharmaceutical Technology

MAY 21, 2024

Glenmark has entered into an exclusive agreement with BeiGene to market and distribute two Beigene oncology medicines in India.

Medicine 130

Medicine Marketing 130

Pharmaceutical Technology

FEBRUARY 28, 2024

Regulatory standards concerning raw material selection are particularly stringent when it comes to Regenerative Medicines.

Medicine 243

Medicine Development 243

Pharmaceutical Technology

MAY 30, 2024

The EC has granted orphan medicinal product designation for Rocket Pharmaceuticals’ RP-A601 for PKP-2 related arrhythmogenic cardiomyopathy.

Medicine 130

Medicine Production 130

Pharmaceutical Technology

MAY 9, 2024

A research project between DMU and the University of Surrey received a grant to help reduce costs for companies in developing medicines.

Medicine 130

Medicine Development Research 130

Pharmaceutical Technology

MAY 23, 2023

The US Food and Drug Administration (FDA) has granted approval for Blueprint Medicines’ Ayvakit (avapritinib) as the first and only treatment for indolent systemic mastocytosis (ISM) in adult patients. The precision therapy has been designed for potently and selectively inhibiting KIT D816V, which is the main underlying driver of the disease.

FDA Approval 246

FDA Approval Medicine Trials Drugs 246

pharmaphorum

JUNE 13, 2024

In a conversation held earlier in the year as the four-year anniversary of the pandemic approached, the pharmaphorum podcast had as guest Murray Aitken, executive director of the IQVIA Institute for Human Data Science, to discuss the state of global medicines and the future outlook when it comes to research and development, and usage and spending appetites. (..)

Medicine 97

Medicine Development Research 97

Pharmaceutical Technology

OCTOBER 12, 2023

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has published updated guidance on valproate-containing medicines.

Containment 147

Containment Medicine Production 147

Outsourcing Pharma

JUNE 27, 2024

Personalized medicine has evolved to the point where it is transforming areas of healthcare, bringing hope to patients across the world.

Medicine 105

Medicine Clinical Development Development 105

Bio Pharma Dive

OCTOBER 24, 2023

Rampart Biosciences closed a Series A round that will fund its goal to develop more potent DNA-based medicines that avoid immune responses.

DNA 265

DNA Medicine Immune Response Development 265

pharmaphorum

JANUARY 11, 2024

In this new episode of the pharmaphorum podcast, host Nicole Raleigh speaks with James Burt, CEO of Pharmanovia, about the value-added medicines space.

Medicine 115

Medicine 115

Pharmaceutical Technology

JUNE 18, 2024

CAR-T Cell Therapy is under clinical development by Shanghai Unicar-Therapy Bio-Medicine Technology and currently in Phase II for Diffuse Large B-Cell Lymphoma.

Medicine 130

Medicine Clinical Development Development 130

Pharmaceutical Technology

JANUARY 31, 2024

Regeneron Pharmaceuticals has formed Regeneron Cell Medicines, a new research & development (R&D) unit in oncology and immunology.

Medicine 130

Medicine Development Research 130

Pharmaceutical Technology

DECEMBER 23, 2022

Eli Lilly and Company has expanded a licencing and partnership agreement with ProQR Therapeutics to discover, develop and market new genetic medicines. The post Lilly and ProQR to expand genetic medicine development agreement appeared first on Pharmaceutical Technology.

Genetics 328

Genetics Medicine Development Gene Therapy 328

Outsourcing Pharma

MARCH 26, 2024

Under the agreement, Closed Loop Medicine â a leading TechBio company â and pharmaceutical company, Teva UK, will investigate opportunities to use Closed Loop Medicineâs proprietary software as a medical device (SaMD) technology platform.

Medicine 103

Medicine Regulation Marketing 103

Pharmaceutical Technology

JANUARY 25, 2024

We speak with BAP Pharma to learn more about the challenges and possible benefits of medicines access solutions.

Medicine 130

Medicine 130

Pharmaceutical Technology

APRIL 18, 2024

Discover the groundbreaking multi-domain active protein patented by Huadong Medicine Co Ltd for treating metabolic diseases. With increased efficacy and simplified preparation process, this protein is set to revolutionize existing treatments.

Protein 130

Protein Medicine 130

Drug Patent Watch

MARCH 7, 2024

LACTOSE-Free Medicines, 2024 is part of DrugPatentWatch’s deep library of business intelligence on biopharmaceutical drugs. Buy Lactose-Free Medicines from Amazon This guide is designed to provide information for healthcare providers to… The post LACTOSE-Free Medicines: Which Drugs Contain LACTOSE?

Containment 111

Containment Medicine Drugs 111

Drug Patent Watch

MARCH 6, 2024

GELATIN-Free Medicines, 2024 is part of DrugPatentWatch’s deep library of business intelligence on biopharmaceutical drugs. Buy Gelatin-Free Medicines on Amazon This guide is designed to provide information for healthcare providers to… The post GELATIN-Free Medicines: Which Drugs Contain GELATIN?

Containment 110

Containment Medicine Drugs 110

Bio Pharma Dive

SEPTEMBER 22, 2023

Results show that the medicine helped patients who progressed on earlier-line treatments live longer than those receiving chemotherapy without their disease getting worse, according to a Friday announcement.

Medicine 166

Medicine 166

Pharmaceutical Technology

JANUARY 9, 2024

BIOS Health has partnered with the City of Bakersfield, Kern County, and Kern Venture Group to set up a precision medicine centre in the US.

Medicine 147

Medicine 147

Pharmaceutical Technology

JANUARY 2, 2024

PYC Therapeutics has announced plans to enter a collaboration with Google Cloud for the development of new precision medicines.

Medicine 147

Medicine Development 147

pharmaphorum

MARCH 27, 2024

Teva UK has joined forces with techbio company Closed Loop Medicine to develop digital companions for pharma products that could provide personalised medicine

Medicine 105

Medicine Pharma Production Production Development 105

BioSpace

MARCH 20, 2024

Mirador Therapeutics emerged from stealth Thursday with financing from ARCH Venture Partners and Sanofi, among others, to provide precision medicines for inflammatory and fibrotic diseases.

Medicine 128

Medicine 128

Pharmaceutical Technology

JANUARY 3, 2024

The UK MHRA has introduced the International Recognition procedure (IRP), a new pathway for medicine approvals.

Medicine 130

Medicine 130

pharmaphorum

APRIL 15, 2024

The advancement of medicine is dependent on secure pharmaceutical supply chains. Discover why ensuring the security of these chains is crucial for the development and distribution of life-saving medications.

Medicine 105

Medicine Development 105

Pharmaceutical Technology

NOVEMBER 8, 2023

NICE is also working on incorporating real-world and AI-generated evidence into medicine evaluation submissions.

Medicine 147

Medicine 147

Pharmaceutical Technology

JANUARY 17, 2024

In a report, findings suggested that cancer patients in the Netherlands will face longer waits to access new oncology medicines.

Medicine 130

Medicine Marketing 130

Outsourcing Pharma

MAY 29, 2024

UK based Celadon Pharmaceuticals Plc, that specializes in the development, production, and sale of breakthrough cannabis-based medicines, announced that it has begun shipping to the US.

Medicine 111

Medicine Sales Production Development 111

Pharmaceutical Technology

JUNE 8, 2023

Biotechnology company Hopewell Therapeutics has raised $25m in seed financing to accelerate the development of next-generation lipid nanoparticles for targeted delivery of genomic medicines. Hopewell Therapeutics is engaged in discovering, synthesising and developing advanced ttLNPs to provide next-generation genomic medicines.

Genome 130

Genome Genomics Medicine Development 130

pharmaphorum

MARCH 12, 2024

Discover why gut bacteria are considered the next frontier in medicine in this informative article. Learn about the importance of the microbiome, its impact on health, and how it relates to conditions like Clostridiales difficile.

Bacteria 126

Bacteria Medicine 126

Pharmaceutical Technology

OCTOBER 25, 2023

A blockchain system intended to ensure the safety and authenticity of medicines across the supply chain could change the way that medical professionals work, as discussed at the 11th Annual Clinical Trial Supply Nordics conference.

Medicine 130

Medicine Clinical Trials Clinical Trials Trials 130

Pharmaceutical Technology

AUGUST 2, 2023

Revolution Medicines has signed a definitive agreement to acquire biopharmaceutical company EQRx in an all-stock transaction.

Medicine 130

Medicine 130

Pharmaceutical Technology

JANUARY 4, 2024

(Amlodipine + indapamide + telmisartan) is under clinical development by George Medicines and currently in Phase III for Hypertension.

Medicine 130

Medicine Clinical Development Development 130

BioSpace

MAY 12, 2024

Medicines that address the causative disease biology underlying central nervous system We are in an unprecedented time in neurotherapeutics.

Medicine 117

Medicine 117

Pharmaceutical Technology

FEBRUARY 27, 2023

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the refusal of the marketing authorisation for Me rck and Ridgeback Biotherapeutics’ Lagevrio (molnupiravir).

Medicine 162

Medicine Regulation Trials Production 162

AuroBlog - Aurous Healthcare Clinical Trials blog

APRIL 8, 2024

The Drugs Technical Advisory Board (DTAB) has suggested to the ministry of health and family welfare (MoHFW) to write to the ministry of corporate affairs to mandate the pharma companies to spend almost one per cent of their net profit for providing free medicines in medicine banks as part of the Corporate Social Responsibility (CSR). […]

Medicine 132

Medicine Pharma Companies Drugs Clinical Trials 132